Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Boyd, GB
Donald Bruce Boyd, Lymington GB
| Patent application number | Description | Published |
|---|---|---|
| 20080272810 | FILTERLESS DIGITAL FREQUENCY LOCKED LOOP - A frequency and/or phase locked loop architecture that eliminates the loop filter generally required in conventional phase locked loops, and which may be implemented in digital logic, for example, as a field programmable gate array. In one example, a frequency/phase locked loop includes both a frequency comparison component and a phase comparison component to allow locking of an output clock signal to both the frequency and phase of a reference signal. | 11-06-2008 |
Edward Boyd, Berkshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20100120840 | Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agents - Objects of the present invention are the compounds of formula (I) their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer. | 05-13-2010 |
Edward Boyd, Tymawr GB
| Patent application number | Description | Published |
|---|---|---|
| 20090221599 | PHTHALAZINONE PYRAZOLE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS - Objects of the present invention are the compounds of formula I | 09-03-2009 |
Ewan Campbell Boyd, Stirlingshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20100036124 | PREPARATION OF AZOXYSTROBIN - The present invention relates, inter alia, to a process for preparing a compound of formula (I): using, as a catalyst 1,4-diazabicyclo[2.2.2]octane. | 02-11-2010 |
| 20100063275 | PROCESS FOR PREPARING 6-PHENOXYPYRIMIDIN-4-OL DERIVATIVES IN THE PRESENCE OF A QUINUCLIDINE OR A N-METHYL PYRROLIDINE DERIVATIVES - The present invention relates, inter alia, to a process for preparing a compound of formula (I): using a quinuclidine-based catalyst or an optionally 3-substituted N-methyl pryrrolidine-based catalyst. | 03-11-2010 |
Ewan Campbell Boyd, Grangemouth GB
| Patent application number | Description | Published |
|---|---|---|
| 20080214587 | Processes For the Preparation of Azoxystrobin Using Dabco as a Catalyst and Novel Intermediates Used in the Processes - The present invention relates, inter alia, to a process for preparing a compound of formula (I): which comprises either (a) reacting a compound of formula (II): with 2-cyanophenyl, or a salt thereof, in the presence of between 0.1 and 2 mol % of 1,4-diazabicyclo[2.2.2]octane, or (b) reacting a compound of the formula (III): with a compound of the formula (IV): in the presence of between 0.1 and 2 mol % of 1,4-diazabicyclo[2.2.2]octane; where W is the methyl (E)-2-(3-methoxy)acrylate group C(CO | 09-04-2008 |
Graham Peter Boyd, Chester GB
| Patent application number | Description | Published |
|---|---|---|
| 20090222060 | SELF CONTAINED DEVICE WITH TREATMENT CYCLE FOR ELECTROSTIMULATION - An electro-stimulation device for the stimulation of the musculature of the pelvic floor complex e.g. for the treatment of anterior and posterior pelvic floor muscle dysfunction is fully self-contained. The device requires no external power sources or control and may be inserted into the vagina or anus through the use of an applicator. The device uses a pre-programmed treatment cycle of stimulating pulses. The cycle comprises either a waveform with an initial phase where the current of the device is ramped from an initial level to a higher level, a second phase where the current is ramped from the higher level from the first phase to a second higher level and a third phase where the current is maintained at the second higher level, or a waveform comprising two or more components each component being a train of regularly spaced pulses or a combination of these two waveforms. | 09-03-2009 |
Ivan Boyd, Ipswich GB
| Patent application number | Description | Published |
|---|---|---|
| 20090136012 | TELECOMMUNICATIONS CALLS - A user accesses a destination such as a call centre | 05-28-2009 |
Ivan Boyd, Ipswich Suffolk GB
| Patent application number | Description | Published |
|---|---|---|
| 20110026934 | TRANSMISSION OF BROADBAND SIGNALS - The invention is concerned with the transmission of broadband signals onto to a telephony connection having constraint profile limiting the maximum allowed power as a function of frequency. As a result, broadband signals can be delivered using low power equipment to a telephony line whilst respecting the constraint profile associated with that line. | 02-03-2011 |
Jamie Boyd, Symington GB
| Patent application number | Description | Published |
|---|---|---|
| 20100133629 | INTEGRATED SENSOR INCLUDING SENSING AND PROCESSING DIE MOUNTED ON OPPOSITE SIDES OF PACKAGE SUBSTRATE - An integrated circuit (IC) device includes a lead frame having a first and a second opposing surface and a plurality of lead fingers. A first die including a signal processor is mounted on the first surface of the lead frame while a second die is mounted on the second surface of the lead frame. The second die includes at least one sensor that senses at least one non-electrical parameter and has at least one sensor output that provides a sensing signal for the parameter. The sensor output is coupled to the signal processor for processing the sensing signal. | 06-03-2010 |
Joseph W. Boyd, Cambridge GB
| Patent application number | Description | Published |
|---|---|---|
| 20110059969 | PIPERAZINES AS ANTI-OBESITY AGENTS - The present invention relates to new compounds of formula (I), to pharmaceutical compositions comprising these compounds, to processes for their preparation, and to the use of these compounds as leptin receptor modulator mimetics in the preparation of medicaments against conditions associated with weight gain, type 2 diabetes and dyslipidemias. | 03-10-2011 |
Joseph W. Boyd, Cambridgeshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20090176798 | New compounds III - The present application relates to new compounds of formula (I), | 07-09-2009 |
| 20090181967 | New compounds I - The present application relates to new compounds of formula (I), | 07-16-2009 |
| 20090281087 | Compounds II - The present application relates to new compounds of formula (I), | 11-12-2009 |
| 20110046135 | NEW COMPOUNDS I - The present application relates to new compounds of formula (I), | 02-24-2011 |
Judith Boyd, Henfield GB
| Patent application number | Description | Published |
|---|---|---|
| 20100317660 | Mediators of hedgehog signaling pathways, compositions and uses related thereto - The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting the cell with a hedgehog antagonist of formula (I) in a sufficient amount to aberrant growth state, e.g., to agonize a normal ptc pathway or antagonize smoothened or hedgehog activity. | 12-16-2010 |
Judith Boyd, West Sussex GB
| Patent application number | Description | Published |
|---|---|---|
| 20090012082 | Mediators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto - The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting the cell with a hedgehog antagonist, such as a small molecule, in a sufficient amount to aberrant growth state, e.g., to agonize a normal ptc pathway or antagonize smoothened or hedgehog activity. | 01-08-2009 |
Malcolm Boyd, Warwickshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20110306947 | MEDICATION DELIVERY DEVICE AND METHOD FOR OPERATING A MEDICATION DELIVERY DEVICE - A medication delivery device comprises a housing having a proximal end (P) and a distal end (D), a cartridge for holding a medication (M), the cartridge having an outlet, a moveable piston being retained within the cartridge, a drive member moveable in a proximal direction with respect to the housing for setting a dose of medication (M) to be delivered and in the distal direction with respect to the housing for delivering the dose and a piston rod adapted to drive the piston in a distal direction with respect to the cartridge for delivering the dose. The drive member is releasably coupled to the piston rod. The medication delivery device further comprises a resilient member which is arranged to move the drive member in the proximal direction with respect to the housing after dose delivery, thereby reducing pressure of the piston rod on the piston. | 12-15-2011 |
Malcolm Boyd, Leamington GB
| Patent application number | Description | Published |
|---|---|---|
| 20100137792 | MEDICATION DELIVERY DEVICE AND METHOD FOR OPERATING A MEDICATION DELIVERY DEVICE - A medication delivery device ( | 06-03-2010 |
Malcolm Richard Boyd, Epsom Surrey GB
| Patent application number | Description | Published |
|---|---|---|
| 20080287389 | Nucleoside analogs in combination therapy of herpes simplex infections - A pharmaceutical product comprising a nucleoside analogue active against herpes simplex virus, such as acyclovir/valaciclovir or peniclovir/famciclovir, and an immunosuppressant, as a combined preparation for simultaneous, separate or sequential use in the treatment and/or prevention of herpes simplex virus infections. | 11-20-2008 |
| 20100323952 | Nucleoside Analogs in Combination Therapy of Herpes Simplex Infections - A pharmaceutical product comprising a nucleoside analogue active against herpes simplex virus, such as acyclovir/valaciclovir or peniclovir/famciclovir, and an immunosuppressant, as a combined preparation for simultaneous, separate or sequential use in the treatment and/or prevention of herpes simplex virus infections. | 12-23-2010 |
Malcolm Stanley Boyd, Warwickshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20120029442 | DRUG DELIVERY DEVICE - The present invention relates to drug delivery devices. The drug delivery device according to the invention includes a housing with a needle holder suitable for attaching a needle unit to the housing at the distal end, and a cap being capable of covering the distal end of the drug delivery device and comprising a retaining member capable of securing the cap by engaging with the housing, the retaining member is prevented from engaging with the housing with the needle unit being attached to the needle holder. Furthermore, using a cap for covering the distal end of the drug delivery device is disclosed. | 02-02-2012 |
Malcolm Stanley Boyd, Warwickshire Warks GB
| Patent application number | Description | Published |
|---|---|---|
| 20120029440 | APPARATUS FOR HOLDING A COVER OF A NEEDLE UNIT AND METHOD - An apparatus comprises a recess configured to hold an outer cover of a needle packaging for providing a needle unit. The outer cover is suitable to cover at least a part of a needle unit for a medication delivery device. | 02-02-2012 |
Mark Thomas Boyd, Handbridge GB
| Patent application number | Description | Published |
|---|---|---|
| 20090017538 | Mammalian MDM2 Binding Proteins and Uses Thereof - Isolated nucleic acid sequences encoding mammalian binding protein and polypeptide sequences for the mammalian MDM2 binding protein are provided. Also provided are vectors containing these nucleic acid sequences, host cells which express these proteins and antibodies targeted to these proteins. In addition, methods and compositions for modulating the G | 01-15-2009 |
| 20100286362 | Mammalian MDM2 Binding Proteins and Uses Thereof - Isolated nucleic acid sequences encoding mammalian MDM | 11-11-2010 |
Nathan Boyd, Manchester GB
| Patent application number | Description | Published |
|---|---|---|
| 20090266154 | IN-BOREHOLE GAS MONITOR APPARATUS AND METHOD - A self-contained in-borehole gas monitor (IGM) apparatus ( | 10-29-2009 |
| 20100132440 | FLUID MONITORING APPARATUS AND A METHOD OF OPERATING THE SAME - A sampling apparatus for sampling a fluid, the apparatus comprising a sensor and a flow regulator open to allow the continuous flow of fluid through the apparatus past the sensor. | 06-03-2010 |
Robert Simon Boyd, Abingdon GB
| Patent application number | Description | Published |
|---|---|---|
| 20100015152 | Diagnostic and therapeutic methods - The present invention provides the use of a protein found in breast, prostate, pancreatic and colon cancer cell membranes, known as BCMP 7, in the diagnosis, screening, treatment and prophylaxis of breast, prostate, pancreatic and/or colon cancer, as well as compositions comprising BCMP 7, including vaccines and antibodies that are immunospecific for BCMP 7. | 01-21-2010 |
| 20110150877 | EPHRIN-B RECEPTOR PROTEIN INVOLVED IN CARCINOMA - The present invention provides a polypeptide (CCMP-1) of use in the diagnosis, screening, treatment and prophylaxis of carcinoma. Also provided are compositions comprising the protein, vaccines and antibodies that are immunospecific for the protein. | 06-23-2011 |
Rod Boyd, London GB
| Patent application number | Description | Published |
|---|---|---|
| 20110246908 | INTERACTIVE AND SHARED VIEWING EXPERIENCE - A shared environment is provided for electronic media devices such as game consoles which have Internet connectivity for receiving streaming video content. The shared environment is a virtual world which includes the video content as well as avatars which represent a group of users who have agreed to watch the content together, and scene elements which provide a realistic and eye-catching appearance. The users can enter commands to cause their avatars to emote, such as by cheering. The users can also explore the shared environment from different camera angles. A voice and/or video chat channel can also be enabled to allow the users to speak to and see one another. The video content is synchronized among the electronic media devices of the users so that the users' interactions are more meaningful as they can react to the same portion of the video content in real time. | 10-06-2011 |
Rodney Alan Boyd, London GB
| Patent application number | Description | Published |
|---|---|---|
| 20090315893 | USER AVATAR AVAILABLE ACROSS COMPUTING APPLICATIONS AND DEVICES - An avatar along with its accessories, emotes, and animations may be system provided and omnipresent. In this manner, the avatar and its accessories, emotes, and animations may be available across multiple environments provided or exposed by multiple avatar computing applications, such as computer games, chats, forums, communities, or instant messaging services. An avatar system may change the avatar and its accessories, emotes, and animations, e.g. pursuant to a request from the user, instructions from an avatar computing application, or updates provided by software associated with a computing device. The avatar and its accessories, emotes, and animations may be changed by a system or computing application associated with a computing device outside of a computer game or computing environment in which the avatar may be rendered or used by the user. | 12-24-2009 |
| 20100009747 | Programming APIS for an Extensible Avatar System - Disclosed is an application programming interface (API) that provides for an extensible avatar system. In one embodiment an API may allow video game applications to retrieve structures of data which represent an avatar. The game can then take those structures and incorporate the data into its own rendering system. In another embodiment an API may allow a video game application to render an avatar to a render target or texture wherein the video game system performs rendering and animation functions. | 01-14-2010 |
Scott Boyd, Cheshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20080207636 | Compounds Effecting Glucokinase - The invention relates to the use of a compound of Formula (I) or a salt, solvate or prodrug thereof, wherein R | 08-28-2008 |